Painless Tattoo Numbing Cream

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the affected area should be cleaned and dried prior to application. The product is to be applied to the affected area no more than 3 to 4 times daily.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Therefore, no specific conditions or situations have been identified in which the product should not be used.

Warnings and Precautions

This product is intended for external use only. It is imperative that healthcare professionals advise patients not to apply the product to wounds or damaged skin, nor to use it in large quantities. Additionally, individuals with known allergies to any of the product's ingredients should refrain from use.

When administering this product, it is crucial to follow the directions provided. Care should be taken to avoid contact with the eyes, rashes, or mucous membranes, as this may lead to adverse effects.

Patients should be instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

To ensure safety, this product must be kept out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not be applied to wounds or damaged skin. It is crucial to avoid using large quantities and to refrain from use if there is a known allergy to any of the ingredients.

While using this product, patients must adhere strictly to the directions provided. Contact with the eyes, rashes, or mucous membranes should be avoided to prevent adverse effects. If the condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients are advised to discontinue use and consult a healthcare professional.

Additionally, this product should be kept out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Painless Tattoo Numbing Cream (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

Elderly patients may use Painless Tattoo Numbing Cream (lidocaine hydrochloride cream) without specific geriatric use considerations, dosage adjustments, or safety concerns noted in the prescribing information. However, as with any medication, it is advisable for healthcare providers to monitor geriatric patients for any potential adverse effects, given the variability in drug metabolism and sensitivity that can occur with aging. Regular assessment of the patient's response to treatment is recommended to ensure safety and efficacy.

Pregnancy

Safety during pregnancy has not been established for this product. Use is not recommended in pregnant women due to potential risks associated with its use. There may be risks to the fetus, and it is advised that pregnant patients consult their healthcare provider for personalized advice regarding the use of this product.

Dosage adjustments may be necessary for pregnant patients; therefore, medical guidance should be sought to ensure appropriate dosing. Pregnant women are encouraged to discuss the use of this product with their healthcare provider prior to application to fully understand the potential risks and benefits.

Lactation

There are no specific warnings or precautions regarding the use of this product in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in terms of dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children and pets to prevent accidental ingestion. Should ingestion occur, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center without delay for guidance on appropriate management.

Prompt action is crucial in mitigating potential adverse effects associated with overdosage. The symptoms may vary depending on the specific substance involved; therefore, a thorough assessment and appropriate intervention are essential.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs. These include allergic reactions such as rash, itching, and hives. Additionally, central nervous system effects have been noted, including seizures and respiratory depression. Cardiovascular effects reported include hypotension and bradycardia.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of safeguarding the medication to ensure the safety of young individuals.

Storage and Handling

This product should be protected from excessive heat and direct sunlight to maintain its integrity and efficacy. It is essential to store the product in a cool, dry place, away from sources of heat and light. Proper handling and storage conditions are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

The medication is administered topically. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the medication, with a maximum frequency of 3 to 4 times daily. For children under 12 years of age, it is advised to consult a doctor prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Painless Tattoo Numbing Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)